/PRNewswire/ Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021.
/PRNewswire/ Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021.
TAIPEI, Taiwan, Dec. 9, 2021 /PRNewswire/ Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021 Biotech Investor Forum, whereby the two parties will jointly invest up to NT$3 billion (approx. US$108 million) to target forward-looking contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs), in response.